Percutaneous Holmium Injection in Pancreatic Cancer
Percutaneous Holmium Injection in Pancreatic Cancer
Active, not recruiting · NCT05880472 · Registry updated 2025-02-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Percutaneous Holmium Injection in Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Not applicable | 2025-02-11 | NCT05880472 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Quirem Medical B.V. | 1 |
| Radboud University Medical Center | 216 |
| Terumo Medical Corporation | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Radboud University Medical Centre | Nijmegen | Netherlands | 2 |